SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is trending as traders debate its potential for a price reversal, citing its low maximum supply and ongoing institutional initiatives as reasons for optimism. While some community members remain skeptical, pointing to the token's historical price decline and competition from other DeFi protocols, others view current price levels as an accumulation opportunity ahead of potential market momentum.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

GoldCoin is experiencing fragmented discussion, with common themes including technical trading strategies, debates regarding its utility as a store of value compared to other assets, and broader speculation about gold-backed digital assets. Some participants are also sharing technical analysis and trading ideas, though consensus remains absent.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased investor attention as the community highlights its recent v5.0 mainnet upgrade and the implementation of native post-quantum security features. While bullish traders emphasize the project's institutional-grade infrastructure and long-term potential as a digital commodity, others express skepticism, citing concerns over long-term price performance and dilution.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is trending amid ongoing debate over its long-term price potential, with many traders expressing frustration over its persistent underperformance relative to other assets while others remain bullish, citing its limited supply and the potential for a long-awaited "caboose" rally. Discussion is heavily focused on technical chart analysis, including debates on support levels and potential breakouts, alongside rumors of institutional interest and comparisons to assets like Bitcoin Cash and Zcash.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing downward price pressure following the release of Phase 3 IZAR-1 trial data, which met primary endpoints but failed to definitively establish the drug as best-in-class for psoriatic arthritis. Traders are expressing disappointment over the results compared to high expectations, while management is drawing criticism for its communication strategy and the filing of a mixed shelf offering.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is seeing heavy discussion surrounding its Q2 earnings report, which highlighted revenue growth, record active riders, and strong free cash flow, though the stock has struggled to maintain gains amid ongoing competition and short interest. Investors remain divided, with many citing the company's valuation and share buyback program as evidence of upside, while others express frustration over stagnant price action and competition from autonomous vehicle players.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

JMIA is trending as traders analyze the company's path toward profitability by late 2026 and monitor technical support levels amid broader market volatility. While investors express strong conviction in the long-term growth of African e-commerce, sentiment remains mixed due to concerns over regional macro headwinds and short-term price fluctuations.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile US is trending as traders debate the potential threat posed by SpaceX's Starlink to the traditional telecom industry, with some investors speculating on the possibility of a buyout or strategic partnership. Additionally, the community is closely monitoring reports regarding potential merger activity between T-Mobile and its parent company, Deutsche Telekom, amid mixed reactions regarding the impact on shareholder value and regulatory hurdles.

Freddie Mac engages in the provision of housing finance system solutions. It operates through the Single-Family and Multifamily segments. The Single-Family segment is involved in purchase, securitization, and guarantee of single-family loans, investments, and management of single-family mortgage credit risk and market risk. The Multifamily segment focuses on purchase, securitization, and guarantee of multifamily loans, investments, securities, and management of multifamily mortgage credit risk and market risk. The company was founded on July 24, 1970 and is headquartered in McLean, VA.

Federal Home Loan Mortgage Corp

Freddie Mac

The community conversation remains focused on the long-anticipated release of Fannie Mae and Freddie Mac from government conservatorship, with traders closely monitoring potential catalysts like IPO plans, legislative housing reforms, and institutional updates from figures like Bill Ackman. Sentiment is heavily divided between long-term holders maintaining conviction in an eventual relisting and those frustrated by the prolonged stagnation and lack of concrete policy movement.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Investors are expressing strong conviction in Internet Computer's long-term utility as a decentralized infrastructure for AI and cloud computing, despite frustration with recent price stagnation. While some traders criticize the project's historical performance and marketing efforts, many are actively accumulating tokens, citing its potential for real-world adoption and unique technological capabilities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alkem Labs CEO Vikas Gupta may exit company

Alkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to depart in the coming months. Gupta joined Alkem from Cipla and has a strong background in the Indian pharmaceutical market.

Semaglutide Ruling Sparks Generic Pharma Boom

… oncology drugs . India's revocation of Novartis … Natco Pharma to launch its version of Roche … Natco Pharma to launch a generic version of Roche … Zydus Lifesciences, Natco Pharma , Alkem Laboratories, and Torrent Pharmaceuticals have developed …

Alkem Laboratories launches semaglutide in India at ₹450 per week, eyes booming weight-loss market

… demand for weight-loss drugs . The patent expiry of semaglutide … active ingredient in blockbuster drugs like Ozempic and Wegovy … to tap the opportunity. Sun Pharmaceutical Industries has launched … 4,200 a month. Glenmark Pharmaceuticals is offering " …

Rs 325–4,200/month: Dr Reddy’s, Sun Pharma, Glenmark kick off generic semaglutide price war

… Reddy’s Laboratories, Sun Pharma , Glenmark Pharmaceuticals , Alkem Laboratories, Zydus Lifesciences … , and Natco Pharma . Eris Lifesciences, which has a … first Indian pharma company to receive approval from the Drugs Controller General …

Alkem Laboratories launches semaglutide in India at Rs 450 per week, eyes booming weight-loss market

Alkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss market. It is available under brand names like Semasize and Obesema. The injection is administered once weekly. Alkem offers a pre-filled pen for a month's dosage at Rs 1,800. This makes the weekly cost Rs 450.

Trading Radar For September 23: Vedanta, KEC International, Birla Corp, NTPC Green Stocks Are On Investors’ Watchlist

Equity

Euro Pratik Sales is set to list on the primary indices today.

From Laurus Labs To Alkem: SEBI Analysts Spot Bullish Setups In These Five Stocks For Short-Term Trades 

Stocks like MCX and Windlas Biotech are showing strong technical momentum, according to analysts. 

Q1 Earnings Review: HAL, Alkem, Abbott Show Strength, Balrampur Faces Mid-Year Test, Says SEBI Analyst

 Q1 earnings delivered a mixed bag, with HAL signalling a recovery, Alkem and Abbott maintaining steady growth, and Balrampur Chini facing near-term pressures

Trump's Pharma Tariff Threat Could Hit Indian Generics – But Will It Stick? SEBI RAs Weigh In 

Pharma stocks declined over fears of U.S. tariffs, but experts remain cautiously optimistic. India’s strength in generics may shield its exporters from any sweeping changes, according to an analyst. 


Momentum Trade Ideas: SEBI RAs See Breakout Opportunities In These Pharma And Industrial Stocks

Analysts have highlighted Jagsonpal, Alkem, Senores Pharma, and Cummins India as strong near-term opportunities based on technical setups and volume action.

Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALKEM.NSE News